Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
about
Metabolic syndrome in the Middle EastHigh levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA studyInflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysisCardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths?Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstreamHelicobacter pylori infection and diabetes: is it a myth or fact?Accurate method to estimate insulin resistance from multiple regression models using data of metabolic syndrome and oral glucose tolerance test.Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice.Glucose supply and insulin demand dynamics of antidiabetic agents.Obesity and inflammation: the linking mechanism and the complicationsPersonality and inflammation: the protective effect of openness to experience.High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneType 2 diabetes and cardiovascular disease: Have all risk factors the same strength?Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese.Predictive factors of non-deterioration of glucose tolerance following a 2-year behavioral intervention.A Polymorphism in Hepatocyte Nuclear Factor 1 Alpha, rs7310409, Is Associated with Left Main Coronary Artery Disease.Systemic inflammation and the metabolic syndrome among middle-aged community volunteers.Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without DiabetesObesity attenuates gender differences in cardiovascular mortality.Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam.The role of serum C-reactive protein measured by high-sensitive method in thyroid disease.Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health StudyCommon variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational StudyAssociation of high sensitive C-reactive protein (hsCRP) with established cardiovascular risk factors in the Indian populationA Bayesian approach for instrumental variable analysis with censored time-to-event outcome.C-reactive protein is linked to lower cognitive performance in overweight and obese womenBody size phenotypes and inflammation in the Women's Health Initiative Observational Study.The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study.Excess cardiovascular risk in diabetic women: a case for intensive treatment.Diabesity: an inflammatory metabolic condition.Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classificationsComparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor.Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effectsEvaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levelsPrevention and treatment of the metabolic syndrome.High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart StudyComparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein.Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.Clinical application of C-reactive protein in stroke prevention: bright and dark sides of the moon.
P2860
Q24604999-DBF1C989-1D33-48F3-9389-D491895BC76BQ24792427-8DF7DC50-DE03-407C-90FB-19CA1FB98F12Q26829404-E9046A96-6859-4B58-91F0-0CBE36A37E95Q28069923-22911A10-1057-4455-8604-D05EF422F65DQ28473422-E3D2947E-DDC4-43CC-89D3-250F76426B6AQ30361927-24CE30C2-B8E7-43C9-847A-44066A4E0AF8Q30824539-E58FC7B0-A296-4BD6-BCF1-9FA4F07E97FCQ33632884-A28F1EBD-DA1F-4B4F-ABCB-4583716FB36EQ33828255-944DCBC1-4102-4F33-9F1F-03937AD56AD8Q33897331-9F47BFDF-2A7E-48B8-9894-47F714B1E0D0Q33966450-2F916892-909F-4CB5-AFFE-095BD7E6010CQ33979763-B4250808-A428-4BD7-BBD1-2633F0AB00BDQ34023548-321DB0F4-B194-40F5-8E46-1081B01F01D9Q34026295-54BEF0BF-C210-4F7B-A7AC-598D4B672D73Q34057227-7DA7413C-354D-47A1-A11B-D4217B87E9B2Q34118788-A452AD2B-17FC-4FF7-B09D-2159DA81399FQ34200504-25E6BB71-5080-4624-95BB-799BAF838E60Q34203358-734B5CC5-462D-4C6C-A373-EB8093455123Q34416707-6C4F449B-C01E-49C4-A42C-606BBFE33C79Q34434856-E1F86683-252F-4B2B-A286-53E68805F15CQ34573865-166C85D1-5794-4E24-98A9-11468FF60380Q34656179-4177F794-A8FB-47FA-95AD-0C8DE65D685CQ34669906-F44074B6-4123-4556-A247-23261453E6BFQ34825493-59C2E5A1-0545-46B9-B455-808D5EB37E37Q35040114-C783602B-A04D-4C87-ABCD-1D181400F3ECQ35050058-AFDDB345-2FAB-48FF-9CAE-DD8B03C0169DQ35072100-0702AFCB-99DB-4413-93CE-7DC5F37DCBBCQ35080636-BB73A101-7ED8-40E0-B186-503EDA72A5A5Q35533775-603757C0-8942-45F0-AFCD-6FE499B1C769Q35576062-1A58647A-93DD-4E2E-838F-CBD8C32A9E90Q35607305-A75B7845-CD3C-4820-A11C-DAA2B55FE45FQ35674514-FBA0F503-9661-4A39-8182-7E079EBC20F3Q35749612-C800E3BF-513F-4B39-989B-37059034E55BQ35827821-0536BE51-E345-48F0-9455-A168FC16EE23Q35898478-2C603D72-9729-4E95-B70A-777FA2B1BF5FQ35952447-2EF29DD4-9BA9-4E48-8026-1A7C1ED3D747Q35973282-CC637FFB-1767-4E22-A937-9DE5480832B8Q36013453-B59566DF-4428-4649-8CDF-20FA4F91D635Q36015883-8459EE0D-8E0A-4E84-A13F-003881F4B7ECQ36107148-3A50B0A4-5B2C-4A7E-BD9C-E1141A7949EA
P2860
Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@en
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@nl
type
label
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@en
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@nl
prefLabel
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@en
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@nl
P2093
P1433
P1476
Prospective study of C-reactiv ...... he Mexico City Diabetes Study.
@en
P2093
Clicerio Gonzalez-Villalpando
Ken Williams
Michael E J Lean
Steven M Haffner
P304
P356
10.2337/DIACARE.25.11.2016
P407
P577
2002-11-01T00:00:00Z